Shares Outstanding for Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's latest reported diluted shares outstanding is 1.50B. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingShares OutstandingSwitch metric
Latest period
1.50B
YoY change
+0.6%
5Y CAGR
+1.1%
Peak year (2011)
1.52B
Latest annual
1.49B
Shares Outstanding history chart for Boston Scientific (BSX) from 1991 to 2025
Shares Outstanding history table for Boston Scientific (BSX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Shares Outstanding | YoY |
|---|---|---|---|---|
| 2025 | 1.49B | +0.6% | ||
| 2024 | 1.49B | +1.5% | ||
| 2023 | 1.46B | +1.7% | ||
| 2022 | 1.44B | +0.4% | ||
| 2021 | 1.43B | +1.2% | ||
| 2020 | 1.42B | +0.4% | ||
| 2019 | 1.41B | +0.7% | ||
| 2018 | 1.40B | +0.6% | ||
| 2017 | 1.39B | +1.1% | ||
| 2016 | 1.38B | +2.7% | ||
| 2015 | 1.34B | -0.5% | ||
| 2014 | 1.35B | +0.5% | ||
| 2013 | 1.34B | -4.7% | ||
| 2012 | 1.41B | -7.4% | ||
| 2011 | 1.52B | +0.1% | ||
| 2010 | 1.52B | +0.7% | ||
| 2009 | 1.51B | +0.6% | ||
| 2008 | 1.50B | +0.8% | ||
| 2007 | 1.49B | +16.7% | ||
| 2006 | 1.27B | +52.1% | ||
| 2005 | 837.33M | -2.2% | ||
| 2004 | 856.45M | +1.6% | ||
| 2003 | 842.86M | +1.7% | ||
| 2002 | 828.89M | -0.2% | ||
| 2001 | 830.77M | +1.3% | ||
| 2000 | 819.78M | -0.6% | ||
| 1999 | 824.44M | +6.2% | ||
| 1998 | 776.47M | -2.9% | ||
| 1997 | 799.55M | +0.5% | ||
| 1996 | 795.71M | +8.1% | ||
| 1995 | 736.00M | +74.8% | ||
| 1994 | 421.05M | +6.5% | ||
| 1993 | 395.20M | +1.2% | ||
| 1992 | 390.34M | +2.7% | ||
| 1991 | 380.00M | — |
Shares Outstanding values are taken from Boston Scientific's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual diluted shares outstanding for Boston Scientific (BSX) came in at 1.49B – edged up 0.6% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Boston Scientific diluted shares outstanding compounded at +1.1% per year, sustaining 10 straight years of year-over-year growth.
Boston Scientific diluted shares outstanding peaked at 1.52B in 2011; the latest annual figure is 1.49B in 2025 (1.6% below peak).
2011 marks the peak diluted shares outstanding at 1.52B, with the historical low of 380.00M recorded in 1991.
Boston Scientific (BSX) sits 5th of 8 Healthcare peers we track on this metric, against a peer median of 1.34B.
Boston Scientific Shares Outstanding by Year
Boston Scientific Shares Outstanding 2025: 1.49B
Boston Scientific diluted shares outstanding in 2025 was 1.49B, edged up 0.6% from 2024.
Boston Scientific Shares Outstanding 2024: 1.49B
Boston Scientific diluted shares outstanding in 2024 was 1.49B, edged up 1.5% from 2023.
Boston Scientific Shares Outstanding 2023: 1.46B
Boston Scientific diluted shares outstanding in 2023 was 1.46B, edged up 1.7% from 2022.
Boston Scientific Shares Outstanding 2022: 1.44B
Boston Scientific diluted shares outstanding in 2022 was 1.44B, edged up 0.4% from 2021.
Boston Scientific Shares Outstanding 2021: 1.43B
Boston Scientific diluted shares outstanding in 2021 was 1.43B.
See more financial history for Boston Scientific (BSX).
Sector peers — Shares Outstanding
Companies in the same sector as Boston Scientific, ranked by their latest diluted shares outstanding.
| Company | Shares Outstanding | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | 4.45B | Healthcare |
| Merck & Co., Inc. (MRK) | 2.51B | Healthcare |
| Johnson & Johnson (JNJ) | 2.43B | Healthcare |
| AbbVie Inc. (ABBV) | 1.77B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | 910.00M | Healthcare |
| Eli Lilly and Company (LLY) | 898.00M | Healthcare |
| AstraZeneca PLC (AZN) | 781.00M | Healthcare |
| Amgen Inc. (AMGN) | 542.00M | Healthcare |
Frequently asked questions
What is Boston Scientific's diluted shares outstanding?
- Latest reported diluted shares outstanding for Boston Scientific (BSX) is 1.50B (period ending March 31, 2026).
How has Boston Scientific diluted shares outstanding changed year-over-year?
- Boston Scientific (BSX) diluted shares outstanding changed +0.6% year-over-year on the latest annual filing.
What is the long-term growth rate of Boston Scientific diluted shares outstanding?
- Boston Scientific (BSX) diluted shares outstanding compound annual growth rate is +1.1% over the most recent 5 years available.
When did Boston Scientific diluted shares outstanding hit its highest annual value?
- Boston Scientific diluted shares outstanding reached its highest annual value of 1.52B in 2011.
What was Boston Scientific diluted shares outstanding in 2024?
- Boston Scientific (BSX) diluted shares outstanding in 2024 was 1.49B.
What was Boston Scientific diluted shares outstanding in 2025?
- Boston Scientific (BSX) diluted shares outstanding in 2025 was 1.49B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BSX Overview
Company profile, financial tools, and key metrics
BSX Revenue Counter
Earns $653.70 every second. See per minute, hour, and day.
BSX Earnings Counter
Earns $112.66 per second net profit. See per minute, hour, and day.
BSX Economic Scale
Exceeds Niger's GDP. Compare with world economies.
BSX What If Invested
What if you had invested $1,000? See historical returns from any date.
BSX How It Makes Money
Discover visual breakdown of $20.61B in revenue — where it comes from and where it goes.
BSX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BSX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BSX Daily Price Character
Balanced · 48.8% historical win rate (green days). Streaks & record days.
BSX Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BSX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.